Skip to content
HW210621 2nd Applied Biocatalysis Summit 2021 logo

 

This event has now run
Get updates for the 2022 version

 

  • Home
  • About
    • About Event
    • Testimonials
    • Content Hub
  • Program
    • Full Event Guide
    • Speakers
  • Partner
    • Partnership Opportunities
    • 2021 Partners
    • Media Partners
  • Take Part
    • Register Interest
    • Contact Us

Cytosurge AG

By emilyl | 29th January 2019

Based on the patented FluidFM technology, Cytosurge AG provides the unique FluidFM BOT system that optimizes CRISPR-Cas transfection by delivering CRISPR-Cas9 complexes directly to where they are required: the nucleus. This is made possible by the FluidFM nanosyringe, which is with its 500 nm aperture probably the world’s smallest syringe. It is ideal for nano-injecting into difficult to transfect cells such as hiPS, neurones and even recently cardiomyocytes.

In addition to nano-injection, the cutting-edge FluidFM BOT system can also perform other unique applications such as single cell isolation and nano-printing.

Seeing is believing – We look forward to meeting you at our booth and discussing how we could help you to optimize your CRISPR experiments.

www.cytosurge.com

OUR CONTACT DETAILS

T: (+1) 617 455 4188
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

This event has now run
Get updates for the 2022 version

SEARCH

ORGANISED BY

HansonWade Logo

 

Terms & Conditions

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.